- Home
- TOMZ vs ALLK Comparison
TOMZ vs ALLK Comparison
Compare TOMZ & ALLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- ALLK
- Stock Information
- Founded
- TOMZ 1979
- ALLK 2012
- Country
- TOMZ United States
- ALLK United States
- Employees
- TOMZ N/A
- ALLK N/A
- Industry
- TOMZ Diversified Commercial Services
- ALLK Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- ALLK Health Care
- Exchange
- TOMZ Nasdaq
- ALLK Nasdaq
- Market Cap
- TOMZ 15.7M
- ALLK 29.5M
- IPO Year
- TOMZ N/A
- ALLK 2018
- Fundamental
- Price
- TOMZ $0.84
- ALLK $0.33
- Analyst Decision
- TOMZ Strong Buy
- ALLK Hold
- Analyst Count
- TOMZ 1
- ALLK 3
- Target Price
- TOMZ $3.50
- ALLK $2.00
- AVG Volume (30 Days)
- TOMZ 16.0K
- ALLK 743.7K
- Earning Date
- TOMZ 05-08-2025
- ALLK 05-20-2025
- Dividend Yield
- TOMZ N/A
- ALLK N/A
- EPS Growth
- TOMZ N/A
- ALLK N/A
- EPS
- TOMZ N/A
- ALLK N/A
- Revenue
- TOMZ $7,738,842.00
- ALLK N/A
- Revenue This Year
- TOMZ $9.68
- ALLK N/A
- Revenue Next Year
- TOMZ $130.22
- ALLK N/A
- P/E Ratio
- TOMZ N/A
- ALLK N/A
- Revenue Growth
- TOMZ 5.22
- ALLK N/A
- 52 Week Low
- TOMZ $0.60
- ALLK $0.22
- 52 Week High
- TOMZ $1.50
- ALLK $1.56
- Technical
- Relative Strength Index (RSI)
- TOMZ 57.28
- ALLK 59.99
- Support Level
- TOMZ $0.79
- ALLK $0.32
- Resistance Level
- TOMZ $0.87
- ALLK $0.33
- Average True Range (ATR)
- TOMZ 0.04
- ALLK 0.00
- MACD
- TOMZ 0.01
- ALLK -0.00
- Stochastic Oscillator
- TOMZ 80.69
- ALLK 79.00
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.